Cloud LAB Act of 2025
- Bill Number
- S. 2676
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Science, Technology, Communications
- Status
- Introduced
- Latest Action
- 2025-08-01: Read twice and referred to the Committee on Commerce, Science, and Transportation.
- Last Updated
- 2025-09-19T14:47:12Z
AI-Generated Summary
Purpose
The Cloud Labs to Advance Biotechnology Act of 2025 (Cloud LAB Act) aims to create a national network of "cloud laboratories"—remote-controlled physical labs equipped with robots and instruments—to boost biotechnology research. It focuses on generating high-quality biological data (information from biological systems like cells or processes) for training artificial intelligence (AI) models and supporting other analyses, while improving access to advanced lab tools for researchers.
Key Provisions
- Definitions: Clarifies terms like "cloud laboratory" (a remotely programmable lab for automated experiments), "biological data," "authorized researcher" (those approved to access data), and "artificial intelligence" (as defined in existing federal law).
- Pilot Program Establishment (Phase I):
- The National Science Foundation (NSF) Director, consulting with the Department of Energy (DOE) Secretary and National Institute of Standards and Technology (NIST) Director, must set up the cloud laboratory network within 360 days of enactment.
- Purposes include cataloging biotech capabilities across labs, connecting researchers to needed tools, and fostering collaboration on data standards and sharing.
- Requires an implementation plan submitted to Congress within 360 days, covering assessments of existing labs, network coordination, data storage and public access, equitable access models (free or low-cost for non-commercial work), intellectual property agreements, industry engagement, and security plans (cybersecurity, biosecurity—protection against biological risks—and research security).
- Estimated costs broken down by year.
- Establishes a Cloud Laboratory Advisory Board (led by NSF) with members from federal agencies, academia, biosafety experts, and industry. The board advises on data priorities, lab development, access equity, safeguards against misuse, and annual reports. It terminates after 12 years.
- Grant Awards for New Labs:
- Phase II: Competitive grants for at least 2 cloud labs within 2 years; fully operational within 3 years; 8-year funding period.
- Phase III: Competitive grants for at least 3 additional labs within 4 years; 6-year funding period, building on Phase II lessons.
- Awards prioritize biotech advancement, with consultations including the Executive Office of the President for biotech coordination.
- Reporting and Oversight: Annual progress reports to Congress starting 1 year after Phase II awards; entire pilot sunsets (ends) after 12 years.
Significant Changes to Existing Law
This bill introduces a new federal pilot program without directly amending prior laws. It builds on existing definitions (e.g., AI from a 2021 defense authorization act) but creates novel requirements for NSF to fund and network cloud labs, coordinate with agencies like DOE and NIST, and establish data-sharing standards. No explicit repeals or modifications to current biotechnology or lab funding laws are mentioned, but it mandates deduplication of efforts across federal programs to avoid overlap.
Potential Impacts
- Government Agencies: NSF gains responsibility for managing grants, networks, and reporting, potentially increasing its biotech role; DOE and NIST provide input on energy/tech standards and coordination. Could enhance interagency collaboration on AI and biotech but requires new appropriations (funding not specified).
- Citizens and Researchers: Improves access to advanced lab equipment and data for underresourced groups (e.g., minority-serving institutions, small colleges), promoting equitable research opportunities. Generates public biological data resources for AI training, accelerating discoveries in health, agriculture, and more.
- International Relations: Indirectly supports U.S. leadership in global biotech and AI by fostering innovation; secure data practices could influence international standards, but no direct foreign policy elements.
Main Stakeholders Affected
- Federal Agencies: NSF (lead), DOE, NIST, and Executive Office biotech coordinators.
- Researchers and Academia: Authorized scientists, especially in biotech fields (e.g., synthetic biology, cell biology); benefits underresourced institutions like historically Black colleges and universities.
- Industry: Biotech companies in health, agriculture, and chemicals; involved in advisory board, data subscriptions, and intellectual property agreements.
- Public and Broader Community: General access to non-proprietary data and tools; safeguards address biosecurity risks for society.
Notable Legal, Constitutional, or Political Implications
- Legal: Emphasizes competitive grants and advisory input, ensuring transparency via congressional reports. Intellectual property and access schemes must balance public benefit with private incentives; biosecurity/cybersecurity plans mitigate risks of data misuse without restricting research freedom.
- Constitutional: Aligns with Congress's spending power (Article I) for science promotion; promotes equal protection through equitable access but could face scrutiny if access processes are deemed unfair.
- Political: Bipartisan introduction (by Sens. Young and Kim) signals support for U.S. competitiveness in AI-biotech; 12-year sunset allows evaluation without permanent commitment. Potential debates on funding levels, data privacy, and industry involvement, but focuses on innovation over controversy.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2025-08-01: Read twice and referred to the Committee on Commerce, Science, and Transportation.
- 2025-08-01: Introduced in Senate
Bill Versions
- Cloud Labs to Advance Biotechnology Act of 2025 — issued 2025-08-01 — PDF (13 pages)